Alzheimer's Parkinson's - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Biogen’s aducanumab evokes debate on FDA approvability in Alzheimer’s disease

Alzheimer’s Parkinson’s
Investigators said they’ve only been shown publicly available percentage results, and so are calling for additional baseline information.